This Working Paper was written by Tenu Avafia, a tralac researcher, and examines the potential impact of the proposed Free Trade Agreement (FTA) between SACU and the United States from the perspective of public health.
Thai academics called on the government on Friday to temporarily suspend ongoing free trade area (FTA) negotiations with the United States, and suggested it to identify impacts on the country’s intellectual property rights and agricultural products.
Today 57 organizations sent a letter to the trade and foreign ministers of EFTA member states urging them not to include provisions that would restrict access to medicines and farmers rights under the EFTA-SACU FTA
Barring major turns, any deal emerging from the talks will be a disaster for most Colombians.
The United States’ continuing concern about Australian laws is threatening to delay the countries’ free-trade agreement.
Korean trade union and social organisations have worked together in recent months to stop the Japan-Korea FTA, arguing that it will result in the abolition of more regulations protecting workers rights, and more privatisation of public services. They also say the average citizens’ access to medical treatment and drugs will also be undermined by the FTA’s excuse to “protect” intellectual property rights.
Prime Minister John Howard may bow to a concerted campaign by American drug companies against the amendments that the government was forced into accepting upon pressure from the Labor Party.
In negotiating trade agreements with Morocco, Chile and other countries, the Bush administration has used the same approach that earned us the enmity of so much of the rest of the world. The bilateral agreements reveal an economic policy dictated more by special interests than by a concern for the well-being of our poorer trading partners.
The European Commission has decided to increase pressure on Israel to adopt more stringent intellectual property protection for the benefit of EU pharmaceutical companies.
Civil groups yesterday called for intellectual property (IP) to be excluded from the second round of the Thai-US Free Trade Agreement (FTA) negotiation because of fears it would give unjustified protection to rich IP developers at the expense of Thais.
HIDDEN at the back of the 1000 page Australia-US Free Trade
Agreement, is a strange article, numbered 21.2(c). Usually,
in a legal document such as a treaty, dispute proceedings
only arise if a party has breached a formal obligation in the text.
Botswana was warned last week by a UN Committee that trade agreements should not undermine Botswana’s ability to ensure access to affordable treatment for children or other people with HIV/AIDS.
Twenty leading medical and legal experts, and seven peak health and community services organisations, will send today an open letter to John Howard and Mark Latham demanding changes to the free trade agreement with the US before the agreement is ratified in late October.
US Trade Representative Robert Zoellick’s warning to Australia that an amended free-trade agreement might conflict with the letter and spirit of the original agreement was prompted by bullying from the American pharmaceuticals industry, according to a US trade adviser.
Tariffs on agricultural products and definitions of intellectual property rights, particularly for pharmaceuticals, are shaping up as the most contentious issues in the free trade negotiations between the United States and three Andean nations, Colombia, Ecuador, and Peru.
The Colombian Germán Velásquez says that it was unfair for the US to veto the Argentine advisor Carlos Correa. He claims that poor countries must continue to have access to cheap medicines even if there are trade treaties. His request is that the Doha agreement is respected.
Australia’s ratification of a free trade agreement with the United States has sparked warnings that it represents a major win for the U.S. drug industry in blocking generic manufacturers and undermining the country’s internationally acclaimed system for lowering pharmaceutical prices.
The funny thing about the free trade agreement with the United States is that Australians and Americans see it as being about completely different things. Australia’s businesspeople see it as about eliminating the barriers to exports and imports between the two countries, which they regard as a good thing.
Kerryn Williams spoke to David Henry, clinical pharmacology professor at Newcastle University and former Pharmaceutical Benefits Advisory Committee member, about how the proposed US-Australia Free Trade Agreement will undermine the Pharmaceutical Benefits Scheme, and increase the price of medicine.
Re: Excluding Intellectual Property from negotiations over
a U.S.- Southern African Customs Union (SACU) Free Trade Agreement